Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Y-27632: A ROCK Inhibitor for Translational Mechanics
2026-09-15
Y-27632 offers a reversible way to interrogate how ROCK-dependent contractility converts cell shape into cytoskeletal organization, focal-adhesion maturation, nuclear YAP signaling, and mesenchymal stromal cell fate. This article translates mechanistic evidence into a practical framework for rigorous, translational experiments.
-
Anti-ROR1 Antibody (Zilovertamab) Workflows
2026-09-14
Build reproducible ROR1 binding, cell-surface phenotyping, and pathway-blockade assays with Anti-ROR1 Antibody (Zilovertamab). This guide also shows how to use the reagent in a carefully bounded extension of deoxynivalenol liver-injury research without confusing an exploratory bridge with validated mechanism.
-
Omega-3 PUFAs Protect Against Cisplatin Nephrotoxicity
2026-09-14
A December 2024 study found that combined EPA and DHA reduced cisplatin-induced kidney injury more effectively than either fatty acid alone in mouse and renal tubular models. Its main mechanistic contribution is linking p62–Keap1–Nrf2 antioxidant signaling with MDM2-mediated suppression of p53-dependent apoptosis, while also examining longer-term renal fibrosis.
-
Prestained Protein Marker for SepM Assay Control
2026-09-13
Learn how a Prestained Protein Marker can strengthen size control and transfer assessment in SepM-related protein studies. This article connects the Triple color protein ladder with the pH-dependent biochemical findings reported in Streptococcus mutans clinical isolates.
-
Cy5 NHS ester(Et): Practical Labeling Guide
2026-09-12
Cy5 NHS ester(Et) is a water-compatible reagent for covalently labeling primary amines in proteins, peptides, and related biomolecules for fluorescence-based detection. It is suited to fresh labeling workflows, but should not be prepared in ethanol or retained as a long-term working solution.
-
Gamma-linolenic acid: Applied Research Workflows
2026-09-11
Build more interpretable inflammation and lipid-signaling experiments with Gamma-linolenic acid (GLA), from receptor-binding studies to viability and apoptosis assay workflows. This guide connects exposure control, orthogonal readouts, and resistance-monitoring principles to practical anti-inflammatory research while highlighting formulation and stability safeguards.
-
AMG 487 for Reliable CXCR3 Assays
2026-09-11
Learn how AMG 487 (SKU B3266) can clarify CXCR3-dependent migration, calcium signaling, macrophage polarization, and assay-related viability concerns. This scenario-based guide translates potency, solubility, storage, metabolism, and literature evidence into practical laboratory decisions.
-
Predicting Netarsudil–siRNA Nanoparticle Codelivery
2026-09-10
Slaughter and colleagues developed a quantitative workflow that predicts whether ionizable drugs can complex siRNA and support nanoparticle encapsulation. Netarsudil was identified as a high-performing candidate and tested with CTGF-targeting siRNA in fibrotic human trabecular meshwork cells, linking formulation design with changes in gene expression and actin organization.
-
Tin Mesoporphyrin IX: HO Assay Workflows
2026-09-10
Tin Mesoporphyrin IX (chloride) provides a direct, nanomolar-affinity tool for testing whether heme oxygenase activity drives metabolic, inflammatory, or antiviral phenotypes. This article translates its biochemical profile into reproducible enzyme, cell-based, and HBV-focused workflows while separating established evidence from practical assay recommendations.
-
Chuanxiong Cortex and Pith in CHD: Metabolomic Insights
2026-09-09
Li and colleagues compared the volatile chemistry and predicted pharmacology of Ligusticum chuanxiong cortex and pith using SPME-GC×GC-MS, network pharmacology, pathway analysis, and molecular docking. The study shows that anatomically distinct rhizome regions contain different candidate bioactive profiles, providing a more resolved framework for interpreting Chuanxiong in coronary heart disease research.
-
Open-Platform DLP for 96-Well Hydrogel Printing
2026-09-09
The reference study introduces an open-platform digital light printer that produces spatially defined two-dimensional hydrogels and activates surface-bound biomolecules in a 96-well format. Its programmable LabVIEW control, planar correction, wavelength flexibility, and vessel compatibility address reproducibility and customization challenges in high-throughput biomaterials workflows.
-
Intraperitoneal CAR-Macrophage Programming via mRNA-LNP
2026-09-09
Gu and colleagues developed a macrophage-targeted mRNA lipid nanoparticle platform to compare 36 CAR designs directly in the peritoneal environment. Their lead CD3ζ–TLR4 intracellular-domain configuration promoted inflammatory macrophage activity, remodeled the tumor microenvironment, increased TCF1+PD-1+ progenitor-exhausted CD8+ T cells, and enhanced responses to PD-1/L1 therapy.
-
Machine Learning Prediction of mRNA Vaccine LNPs
2026-09-08
Wang and colleagues developed a LightGBM model to predict lipid nanoparticle formulations for mRNA vaccines from 325 formulation–IgG titer records. The study combined machine learning, mouse validation of DLin-MC3-DMA versus SM-102, and molecular dynamics to connect formulation variables with vaccine performance and provide a basis for virtual LNP screening.
-
Reserpine (N1867): Practical Lab Workflow Guide
2026-09-07
Reserpine (N1867) is a high-purity research reagent for controlled neurotransmitter depletion research, antihypertensive mechanism studies, and neuropharmacology research. This guide covers identity verification, DMSO preparation, storage, and quality-control practices; it is not intended for diagnostic, therapeutic, clinical, or veterinary use.
-
Berberine Hydrochloride: Assay Logic for Gut–Bone Research
2026-09-07
Berberine hydrochloride connects AMPK, epithelial biology, microbiota, and osteoimmune readouts. This article provides a salt-aware, causality-focused framework for integrating metabolic and gut–bone assays without overstating preclinical evidence.